NCT00359801
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Pfizer Investigational Site Bay Minette, Alabama, United States
- Pfizer Investigational Site Fairhope, Alabama, United States
- Pfizer Investigational Site Graysville, Alabama, United States
- Pfizer Investigational Site Pell City, Alabama, United States